海外研究留学報告 福島賢慈 東京女子医科大学 画像診断 核医学部 核医学地方会 2011 Jan

Similar documents
RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING

Conflict of Interest Disclosure

CARDIAC PET PERFUSION IMAGING with RUBIDIUM-82

Promising New Fluorine-18 Labeled Tracers for PET Myocardial Perfusion Imaging

Positron emission tomography and molecular imaging

Myocardial Perfusion: Positron Emission Tomography

PET myocard perfusion & viability Riemer Slart

SPECT or PET for Cardiovascular Screening in High-Risk Patients

Nuclear Cardiology Cardiac Myocardial Perfusion with 82 Rb. Dominique Delbeke, MD, PhD Vanderbilt University Medical Center Nashville, TN

Pearls & Pitfalls in nuclear cardiology

Myocardial blood flow PET evaluation and quantification. Dr. Erick Alexánderson. Rosas

Advantages of PET Myocardial Imaging

Adriano Duatti Department of Chemical and Pharmaceutical Sciences University of Ferrara Via L. Borsari, 46, Ferrara, Italy

NUCLEAR CARDIOLOGY UPDATE

Nuclear Cardiology Pierre-Yves MARIE Department of Nuclear Medicine CHU-Nancy, FRANCE.

Present and Future PET MPI Agents

The Role of Nuclear Imaging in Heart Failure

Preview of Presentation

Current Tracers. João V. Vitola, MD, PhD. Cardiologist and Nuclear Medicine Physician Quanta Diagnostico Nuclear Curitiba - Brazil

Je bénéficie régulièrement de fonds privés, dans le cadre de projets de recherche ou d activités de formation.

SPECT CT Current Status and Future Direction Nuclear Cardiology

New Challenges in Nuclear Cardiology Practice

Typical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?

Myocardial perfusion scintigraphy using rubidium-82 positron emission tomography

Hybrid imaging of the heart

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Advances in Cardiovascular Molecular Imaging: Hybrid SPECT/CT, PET/CT, and PET/MRI

Emerging role of PET in nuclear cardiology. Dr. Erick Alexánderson. Rosas

SPECT-CT: Τι πρέπει να γνωρίζει ο Καρδιολόγος

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Molecular Imaging of Coronary Plaques

Effects of Motion and Tissue Weighting on PET Myocardial Blood Flow Estimates

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Update in Nuclear Cardiology: Patient-Centered Imaging Radiation Dose Reduction

PET: quantification of perfusion and beyond

Cardiac Positron Emission Tomography

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

Rubidium-82 myocardial perfusion PET/CT

Identifying Image Artifacts, Their Causes and How to Fix Them: PET. Brad J Kemp, PhD Mayo Clinic, Rochester, MN

Cardiac PET. John Buscombe

Le FDG dans l évaluation de la viabilité : Quelle place par rapport aux autres traceurs?

The development of combined PET/CT scanners has

Hospital, 6 Lukon Road, Lukong Town, Changhua Shien, Taiwan 505, Taiwan.

New Developments / Technologies / Protocols in NC

Zahid Rahman Khan, MD(USA), MS Diplomate American Board of Nuclear Medicine Consultant t Nuclear Medicine

Fundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC

Cardiovascular Imaging

Previous MI with no intervention

@02-126_Coronary_calcification.ppt. Professor Molecular and Medical Pharmacology

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

CHRONIC CAD DIAGNOSIS

Tc-99m Sestamibi/Tetrofosmin Stress-Rest Myocardial Perfusion Scintigraphy

Myocardial Perfusion SPECT How to do it E. Moralidis

Patient-centered Imaging in Coronary Artery Disease. Jason H Cole, MD, MS, FACC January 10, 2015

The Role of SPECT/ PET

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

Abnormal, Autoquant Adenosine Myocardial Perfusion Heart Imaging. ID: GOLD Date: Age: 46 Sex: M John Doe Phone (310)

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Appropriateness of Stress Echocardiography and Nuclear Stress Thallium/Sesta Mibi Testing Methods

New Insight about FFR and IVUS MLA

Combining Coronary Artery Calcium Scanning with SPECT/PET Myocardial Perfusion Imaging

Hybrid Imaging Improving Nuclear Cardiology Practice

For myocardial perfusion SPECT, professional societies recommend

Stress only Perfusion Imaging

O is characterized by different kinetic properties as compared with 13 NH 3

Machine learning improves image analysis prognosis and diagnosis in cardiac imaging

Radiologic Assessment of Myocardial Viability

PET for the Evaluation of Myocardial Viability

Cardiac Imaging Tests

Dual-Tracer Gated Myocardial Scintigraphy

Nuclear medicine in general practice. Dr Reza Garzan MD, FRACP, FAANMS

Rational use of imaging for viability evaluation

Myocardial flow reserve (MFR) with positron emission tomography (PET)/computed tomography (CT): clinical impact in diagnosis and prognosis

EDITORIAL. Guiding coronary revascularization using PET stress myocardial perfusion imaging: The proof is in the pudding

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

Optimal testing for coronary artery disease in symptomatic and asymptomatic patients

PET MPI Limitations of SPECT MPI

Treadmill Exercise Produces Larger Perfusion Defects Than Dipyridamole Stress N-13 Ammonia Positron Emission Tomography

Tailoring Cardiac stress testing. When and how to use Exercise, Vasodilators and Inotropes.

MR Assessment of Myocardial Viability

Comparison between 1-compartmental and 2-compartmental model in calculation of myocardium blood flow in 82 Rb PET imaging

. θωρακικούάλγουςστα εξωτερικά ιατρεία

4D PET: promises and limitations

PET and PET/CT in CLINICAL CARDIOLOGY

Welcome! To submit questions during the presentation: or Text:

Evidence for Everyone: Expanding the Reach of Health Technology Assessment 2016 CADTH Symposium, April 10-12, Shaw Centre, Ottawa

Disclosure Information

NUCLEAR CARDIOLOGY AND ADVANCED VASCULAR IMAGING. Joel Kahn, MD, FACC

SPECT TRACERS Tl-201, Tc-99m Sestamibi, Tc-99m Tetrofosmin

Diabetes and Occult Coronary Artery Disease

I have no financial disclosures

CT or PET/CT for coronary artery disease

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

Click here for Link to References: CMS Website HOPPS CY 2018 Final Rule. CMS Website HOPPS CY2018 Final Rule Updated November 2017.

Photon Attenuation Correction in Misregistered Cardiac PET/CT

Multimodality Imaging in Cardiac Stem Cell Research

João V. Vitola, MD, PhD

Which Test When? Avoid the Stress of Stress Testing. Marc Newell, MD, FACC, FSCCT Minneapolis Heart Institute

Evidence for myocardial CT perfusion imaging in the diagnosis of hemodynamically significant coronary artery disease

Transcription:

2011 Jan

Maryland state (MD), USA

Maryland state (MD), USA

Baltimore city, MD

Baltimore city, MD

Myocardial Perfusion PET tracers PET Tracers Half life Production First Pass Extraction Kinetic Properties 13N Ammonia 10 min Cyclotron 85% Metabolic trapping 82Rb 76 sec Generator 65% Na/K ATPase channel 15O H 2 O 122sec Cyclotron 100% Freely diffusible 18F flurpiridaz 110 min Cyclotron or Delivery 90% Binds to mitochondrial complex-1 FDA approved Heart Fail Rev 2010

Protocol for Pharmacological stress with 82 Rb Myocardial Perfusion PET

Dypiridamole: 7min Adenosine: 3-4min Protocol for Pharmacological stress with 82 Rb Myocardial Perfusion PET

Dypiridamole: 7min Adenosine: 3-4min Rergadenoson (selective A2A agonist) Available for rapid infusion Less side effects Protocol for Pharmacological stress with 82 Rb Myocardial Perfusion PET

Case 1. 52 years Female w/ Chest pain Risk factors: HT, HLp, Smoking, Obese (108kg) Stress Rest Stress Rest Stress Rest 99m Tc-tetrofosmin (10 th Oct 2007) 82 Rb (16 th Oct 2007)

Case 2. 51 years Female w/ Short of breath Risk factors: HT, DM, Dialysis Stress Rest Stress Rest Stress Rest 99m Tc-tetrofosmin (17 th May 2009) 82 Rb (26 th May 2009)

Diagnostic accuracy of 82 Rb myocardial perfusion PET: comparison with 99m Tc sestamibi SPECT Bateman et al J Nucl Cardiol 2006

Prognostic value of 82 Rb myocardial perfusion PET Normal Rb perfusion Abnormal Rb perfusion Yoshinaga et al JACC 2006

Prognostic value of 82 Rb myocardial perfusion PET Courtesy; CME Cardiac PET

Courtesy; CME Cardiac PET

18 F flurpiridaz (formerly BMS747158 ) 18 F-BMS-747158-02: analogue of the insecticide pytidaben Rat myocardium Pig heart Higuchi et.al JNM2008 Nekora et.al Circulation 2009

Clinical advantages of hybrid PET-CT for cardiac study Conventional analysis w/ CT based attenuation correction (Myocardial perfusion, cardiac function, and volume) Myocardial flow quantification GE Discovery 64 slice PETCT Cardiac CT (Coronary imaging, Plaque analysis, Calcium scoring and delayed image)

PET Tracer Uptake Vs. Myocardial Blood Flow Courtesy; CME Cardiac PET

Myocardial Flow Measurement with Dynamic PET Boogers, Fukushima et.al Heart Fail Rev 2010

Long term prognostic value of coronary flow reserve (CFR) by 13 N Ammonia Herzog, Husman et.al JACC 2009

Prognostic usefulness of myocardial flow reserve (MFR) by 82 Rb PET Perfusion Flow Reserve M Schwaiger, High lights lecture SNM2010

Prognostic usefulness of myocardial flow reserve (MFR) with normal perfusion by 82 Rb PET Stress Flow Flow Reserve Fukushima, Javadi et.al JNM 2011 in press

Routine utility Translation of Basic Science to Clinical Application Clinical study Clinical trial Large mammals Rabbit mouse rat Vivo imaging Conception Ex vivo imaging or Kinetics

Angiotensin II type 1 receptor imaging The angiotensin II type 1 receptor (AT1R) is the primary receptor of the RAAS in myocardium. Experimental studies suggest that it mediates proinflammatory, proapoptotic and profibrotic processes in maladaptive conditions. Clinically, it has been shown that AT1R blockade improves outcome after myocardial infarction. Carbon-11 labeled AT1R blocker

Imaging of cardiac RAS activation after myocardial infarction using rat model Myofibroblast Higuchi, Fukushima et.al JNM 2010

Imaging of cardiac RAS activation after myocardial infarction using rat model Higuchi, Fukushima et.al JNM 2010

Species variability of Myofibroblast expression in myocardial infarction Gallagher AM et.al Am J Physiol 1998

AT1R expression in pig model of myocardial infarction Van Katz JP et.al Circulation 2000

AT1R expression in pig model of myocardial infarction Van Katz JP et.al Circulation 2000

Experimental myocardial infarction Balloon occlusion C-Arm fluoroscopy (Siemence) Balloon occlusion LAD mid for 90 120min Reperfusion

Large animal study with clinical scanner

Healthy Animal 16.7KBq/mL 11 C KR31173 (AT1R) SA HL 0 MIP 13 NH 3 (Perfusion) Axial PET CT VL 130KBq/mL SA HL 0 MIP Axial PET CT VL CVC SNM2010 at Salt lake city

Binding Specificity with healthy pig 15MBq/ml 15MBq/ml 0 Control 0 Blocking (SK 1080, 2mg/kg iv) CVC SNM2010 at Salt lake city

PET CT After Myocardial Infarction CT Delayed Enhancement (Scar) SA VLA HLA 13 NH 3 (Perfusion) 115KBq/mL 0 11 C KR31173 (AT1R) 29KBq/mL 2weeks after MI 0 CVC SNM2010 at Salt lake city

Regional Analysis 11 C KR Retention 11 C-KR31173 Retention Index Ml Pig 8 ** (P<0.01 vs all others) 6 0 5.6 4 * (P<0.01 vs all others) Control 2 0 Control Infarct Remote (Lateral) 0 5.6 Ml Group M Schwaiger, High lights lecture SNM2010

Established in 2007 Honored by Dr. Wagner & Dr. Torizuka Sponsored by Nihon medi physics US $48000 for two years (approximately $8,000 every 3 months)

SNM Wagner Trizuka fellowship Colloquium Banquet SNM2010 at Salt lake city SNM2009 at Toronto Ca

Acknowledgement Research team Higuchi T, Javadi MS, Lautamaki R, Takuro I, Fung G, Bravo P, Rischpler C, Chen D, Flotats A, and Bengel FM PET center Voicu C, Ramos A, Merrill J, Willet M Cyclotron Ravert H, Mathews B, Dannals RB, Brown J Laboratory Xia J, Angels J, Lee L, and Wahl RL Veterinary surgeon stuff DiPaula A, Tunnin R Financial support SNM/ Nihon Medi physics Thank you!!